1/30/2014

FDA reviewers said study data appear to show naproxen does not carry the cardiovascular risks that other nonsteroidal anti-inflammatory drugs do, and the FDA may consider revising the label warning for the drug. All NSAID drugs got boxed warnings in 2005 indicating cardiovascular risks.

Related Summaries